-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Pacira BioSciences, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2011 to 2023.
- Pacira BioSciences, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $4.61M, a 19.7% decline year-over-year.
- Pacira BioSciences, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $35.8M, a 1122% increase year-over-year.
- Pacira BioSciences, Inc. annual Income Tax Expense (Benefit) for 2023 was $19.7M.
- Pacira BioSciences, Inc. annual Income Tax Expense (Benefit) for 2022 was -$2.61M, a 118% decline from 2021.
- Pacira BioSciences, Inc. annual Income Tax Expense (Benefit) for 2021 was $14.4M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)